eTute 1 - How Drugs Work - A Basic IntroductioneTute 1 - How Drugs Work - A Basic Introduction Flashcards
describe important routes of drug administration.
distinguish between pharmacokinetics and pharmacodynamics.
describe absorption, distribution, metabolism, excretion, and the plasma concentration-time curve of a drug.
describe the characteristics of four receptor superfamilies.
describe agonists and antagonists with examples (recognising that ligand-receptor interaction is mostly reversible).
describe agonists, antagonists, affinity, efficacy, concentration-response relationship, potency, and EC50 in the context of ligand-receptor interaction.
describe the effectiveness of a drug and its relevance to choosing drug treatments.
drugs typically change how existing biological processes happen - usually they can’t directly rebuild or restore damaged parts of the body, although they sometimes slow down cell damage, or stimulate the body to repair itself.
very often, drugs are used to treat the symptoms, not the cause of a disease. There are some important exceptions to this. For example, antibacterial drugs such as penicillin, or antifungal drugs like itraconazole, are used to kill populations of unwanted pathogenic microorganisms established within the body.
note too that the human body can be a source of drugs: chemists can extract and then synthesise particular hormones that already exist in the body, and use them as treatments, e.g., adrenaline, insulin.
prophylaxis – that is, to prevent the outbreak of sickness or disease in patients who are otherwise healthy.
pharmacokinetics
Oral Route: This is the easiest and most common way of administering drugs. Drugs given by the oral route can be formulated in many ways including liquid suspensions, capsules, pills, or tablets. There are various additives and materials that are combined with the drug during the pill manufacturing process, to ensure that drug release occurs at the right time in the right place within the gastrointestinal tract (GI tract). This harsh environment can be a tough place for acid-sensitive drug molecules!
Drugs that are broken down by gastric acids can be surrounded by acid-resistant protective layers (known as enteric coatings) that remain intact in the stomach and then release their payload from the pill core within the upper intestines where the pH environment is less acidic.
With oral dosing, drug molecules may be broken down by enzymes in the GI tract wall and liver before they ever reach the bloodstream, a process known as first-pass metabolism. The resulting drug metabolites usually lose their affinity for their respective drug target, so they are unable to induce a pharmacological response. Another limitation is that it often takes an hour or two for full absorption to occur from the intestines - clearly a problem if patients are in a life-threatening condition and need urgent relief.
A few anti-HIV (human immunodeficiency virus) drugs have also been approved to be used for prophylaxis. In a slightly more unusual case of prophylaxis, oral contraceptives are taken by healthy women of childbearing age to decrease the likelihood of becoming pregnant, not to prevent a disease.
Dermal Route: Also known as topical administration, this involves the application of drugs directly to the skin. Absorption can be limited by the tough epidermal layer and stratum corneum that protects the body against incoming chemical invaders. This can involve mixing the drug into ointments and creams. Adhesive skin patches are also a convenient way to administer drugs such as nicotine or nitroglycerin.
Injection: Drugs that are injected directly into the skin, muscle or bloodstream will bypass the gut and liver, and usually act more quickly than oral medication. Injections can be subcutaneous (under the skin), intradermal (between the top layers of skin), intramuscular (directly into large muscles) and intravenous (directly into the vein). Each of these results in a different time-course of drug release into the blood.
Since these drug delivery methods carry a risk to patients, they require special training and expertise, and their use is often restricted to hospitals and other clinical settings. They are especially useful in emergency settings where a rapid drug response is needed.
Inhalation: A variety of drugs for asthma and other lung diseases can be inhaled directly into the lungs. Depending on the drug, formulations for delivery via the lungs include gases, aerosol puffers or devices that dispense puffs of finely ground drug particles.
Other Routes: Depending on the condition being treated and the drug in question, a wide variety of methods can be used:
Suspensions like eye or ear drops.
Nasal sprays.
Suppositories inserted into the bowel and absorbed through the bowel wall.
Pessaries inserted into the vagina and absorbed through the vaginal wall.
Sublingual medications that are held under the tongue and dissolved.
Buccal medications which are held against the inside of the cheek and dissolved.
Bioavailability refers to the fraction of the dose ingested by a patient that reaches the bloodstream. It is symbolised using the letter ‘F’ (for fraction), and ranges from 0.1 - 1.0 for most widely used medicines. Obviously, the closer to 1.0 the better, because this means that as much of the drug given to patients reaches the circulation as possible. By definition, a drug that is administered intravenously has a bioavailability of 1.0.
Now that we’ve gotten the drug into the bloodstream, we need to break it down further. These changes to the chemical structure are called metabolism. The changes mostly occur in the liver as it is rich in drug-metabolising enzymes (DMEs), although other tissues/organs, e.g., the gut wall, kidneys, and brain, can also metabolise drugs. Note that orally administered drugs can undergo metabolism as they make their way through the gut wall and the liver before reaching the bloodstream, a process known as first-pass metbolism.
Tiny molecular pumps known as drug transporters control the movement of drugs across most membranes and from one body compartment to another.
Transporters (shown as ‘T’s in the diagram) regulate the movement of drugs out of the bloodstream and into a wide range of organs and tissues, including the heart, lungs, liver, brain and mammary tissue.
DMEs within these tissues turn the drug molecules into water-soluble derivatives (metabolites). This is the body’s way of protecting itself against accumulating ‘greasy’ foreign chemicals acquired from outside.
The most common thing to happen to the drug molecule as it is metabolised is that it picks up a new oxygen atom. It does this by interacting with a DME.
The most important family of DMEs are the cytochrome P450 (CYP450) proteins which live mostly in liver cells and the gut wall cells.
Cytochrome P450 is nicknamed ‘Nature’s blowtorch’ because it is a powerful oxidising system that efficiently adds oxygen (O) atoms to foreign chemicals and helps them to be broken down into metabolites.
It’s common for drugs to form multiple metabolites during passage through the liver, with many drugs forming dozens of metabolites within the body.
Some penicillins are excreted mostly via urine.
Metformin, a widely used anti-diabetes drug, also undergoes minimal metabolism in the liver and is excreted as the parent or unchanged drug in urine.
Other drugs are excreted partly through sweat:
lead, mercury and other heavy metals
alcohol
Some are excreted partly through the breath:
alcohol again
some gas anaesthetics
Profile A shows the ‘happy medium’ where we want the drug to have an effect, but not harm the person. This shows when the drug had peak concentration in the person’s blood sample. The area shown in yellow is what we call the therapeutic window - the range of drug concetrations that produces therapeutic effect and does no harm.
Profile B shows the same drug being tested in three different routes, to see how long it lasts and when its concentration peaks in the blood sample. The IV dose shows the highest concentration, as you’d expect, as it’s been injected straight into the bloodstream. By contrast, the oral dose took time to break down, and the subcutaneous dose - injected under the skin - peaked earlier, but wasn’t as concentrated in the bloodstream.
Profile C shows a drug being given in oral doses over time so that its concentration is accumulating and rising in the body. If we keep going like this, we’ll hit toxicity, so we need to stop before we reach that point.